Drug Shortage Report for SANDOZ AZITHROMYCIN
Report ID | 163234 |
Drug Identification Number | 02332396 |
Brand name | SANDOZ AZITHROMYCIN |
Common or Proper name | AZITHROMYCIN |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 200MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 37,5ML POS |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2022-06-22 |
Estimated end date | 2022-07-22 |
Actual end date | 2022-07-20 |
Shortage status | Resolved |
Updated date | 2022-07-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-07-21 | English | Compare |
v9 | 2022-07-20 | French | Compare |
v8 | 2022-07-20 | English | Compare |
v7 | 2022-07-13 | French | Compare |
v6 | 2022-07-13 | English | Compare |
v5 | 2022-07-06 | French | Compare |
v4 | 2022-07-06 | English | Compare |
v3 | 2022-06-23 | English | Compare |
v2 | 2022-06-22 | French | Compare |
v1 | 2022-06-22 | English | Compare |
Showing 1 to 10 of 10